Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac-Lidocaine for Hemodynamic Control in C-Section with Valvular Heart Disease
NCT01571791Phase 2Suspended
- Sponsor
- Mansoura University
- Start
- Jun 2012
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketorolac, Lidocaine Hydrochloride Injection, without epinephrine in valvular heart disease (VHD), sponsored by Mansoura University. Started Jun 2012; status: suspended.
02
Drugs
ketorolacLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
valvular heart disease (VHD)
Beyond the preview
Go deeper on NCT01571791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01571791.